Show simple item record

dc.contributor.authorWebster, L.*
dc.contributor.authorGroskreutz, D.*
dc.contributor.authorGrinbergs-Saull, A.*
dc.contributor.authorHoward, R.*
dc.contributor.authorO'Brien, J.T.*
dc.contributor.authorMountain, Gail*
dc.contributor.authorBanerjee, S.*
dc.contributor.authorWoods, B.*
dc.contributor.authorPerneczky, R.*
dc.contributor.authorLafortune, L.*
dc.contributor.authorRoberts, C.*
dc.contributor.authorMcCleery, J.*
dc.contributor.authorPickett, J.*
dc.contributor.authorBunn, F.*
dc.contributor.authorChallis, D.*
dc.contributor.authorCharlesworth, G.*
dc.contributor.authorFeatherstone, K.*
dc.contributor.authorFox, C.*
dc.contributor.authorGoodman, C.*
dc.contributor.authorJones, R.*
dc.contributor.authorLamb, S.*
dc.contributor.authorMoniz-Cook, E.*
dc.contributor.authorSchneider, J.*
dc.contributor.authorShepperd, S.*
dc.contributor.authorSurr, Claire A.*
dc.contributor.authorThompson-Coon, J.*
dc.contributor.authorBallard, C.*
dc.contributor.authorBrayne, C.*
dc.contributor.authorBurke, O.*
dc.contributor.authorBurns, A.*
dc.contributor.authorClare, L.*
dc.contributor.authorGarrard, P.*
dc.contributor.authorKehoe, P.*
dc.contributor.authorPassmore, P.*
dc.contributor.authorHolmes, C.*
dc.contributor.authorMaidment, I.*
dc.contributor.authorMurtagh, F.*
dc.contributor.authorRobinson, L.*
dc.contributor.authorLivingston, G.*
dc.date.accessioned2018-01-11T09:48:15Z
dc.date.available2018-01-11T09:48:15Z
dc.date.issued2017-05
dc.identifier.citationWebster L, Groskreutz D, Grinbergs-Saull A et al (2017) Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations. Health Technology Assessment. 21(26)en_US
dc.identifier.urihttp://hdl.handle.net/10454/14461
dc.descriptionYesen_US
dc.description.abstractWe defined disease-modification interventions as those aiming to change the underlying pathology. We systematically searched electronic databases and previous systematic reviews for published and ongoing trials of disease-modifying treatments in mild-to-moderate dementia. We included 149/22,918 of the references found; with 81 outcome measures from 125 trials. Trials involved participants with Alzheimer's disease (AD) alone (n = 111), or AD and mild cognitive impairment (n = 8) and three vascular dementia. We divided outcomes by the domain measured (cognition, activities of daily living, biological markers, neuropsychiatric symptoms, quality of life, global). We calculated the number of trials and of participants using each outcome. We detailed psychometric properties of each outcome. We sought the views of people living with dementia and family carers in three cities through Alzheimer's society focus groups. Attendees at a consensus conference (experts in dementia research, disease-modification and harmonisation measures) decided on the core set of outcomes using these results. Recommended core outcomes were cognition as the fundamental deficit in dementia and to indicate disease modification, serial structural MRIs. Cognition should be measured by Mini Mental State Examination or Alzheimer's Disease Assessment Scale-Cognitive Subscale. MRIs would be optional for patients. We also made recommendations for measuring important, but non-core domains which may not change despite disease modification.en_US
dc.description.sponsorshipThe National Institute for Health Research Health Technology Assessment programmeen_US
dc.language.isoenen_US
dc.relation.isreferencedbyhttps://doi.org/10.3310/hta21260en_US
dc.rights© Queen’s Printer and Controller of HMSO 2017. Reproduced in accordance with the UK government’s non-commercial license for public sector (http://www.nationalarchives.gov.uk/doc/non-commercial-government-licence/version/2/)en_US
dc.subjectDementia; Disease modification trialsen_US
dc.titleDevelopment of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendationsen_US
dc.status.refereedYesen_US
dc.typeReporten_US
dc.type.versionPublished versionen_US
refterms.dateFOA2018-07-28T02:19:07Z


Item file(s)

Thumbnail
Name:
webster_et_al_2017.pdf
Size:
5.905Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record